We are live on ! Find out more
Belvedere Trading

Belvedere Trading Portfolio holdings

AUM $87.6B
1-Year Est. Return 131.08%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+131.08%
3 Year Est. Return
+497.29%
5 Year Est. Return
+787.25%
10 Year Est. Return
AUM
$3.82B
AUM Growth
+$2.48B
Cap. Flow
+$2.44B
Cap. Flow %
63.89%
Top 10 Hldgs %
92.79%
Holding
683
New
348
Increased
67
Reduced
55
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 4.25%
2 Consumer Discretionary 0.64%
3 Healthcare 0.37%
4 Industrials 0.21%
5 Financials 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENG
626
CALL
DELISTED
ENGlobal Corp
ENG
-5,038
Closed -$105K
GMDA
627
CALL
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-37,100
Closed -$220K
GOEV
628
CALL
DELISTED
Canoo Inc. Class A Common Stock
GOEV
-35
Closed -$138K
GOEV
629
PUT
DELISTED
Canoo Inc. Class A Common Stock
GOEV
-11
Closed -$43K
POL
630
DELISTED
Polished.com Inc.
POL
-650
Closed -$103K
GERM
631
DELISTED
Amplify Treatments, Testing and Advancements ETF
GERM
-10,313
Closed -$410K
ONCT
632
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-2,054
Closed -$170K
NMRD
633
CALL
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
-39,300
Closed -$315K
AVTA
634
DELISTED
Avantax, Inc. Common Stock
AVTA
-13,194
Closed -$213K
SCU
635
PUT
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-15,000
Closed -$342K
BTWN
636
DELISTED
Bridgetown Holdings Limited Class A Ordinary Shares
BTWN
$0 ﹤0.01%
+1
New +$10
ZYNE
637
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-44,000
Closed -$205K
ZYNE
638
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-2,500
Closed -$12K
NEX
639
DELISTED
NexTier Oilfield Solutions Inc.
NEX
-697,072
Closed -$2.54M
PTRA
640
DELISTED
Proterra Inc. Common Stock
PTRA
-10,023
Closed -$114K
HGEN
641
DELISTED
HUMANIGEN, INC.
HGEN
-41,548
Closed -$584K
ISEE
642
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-3,508
Closed -$38.2K
EVLO
643
CALL
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-65
Closed -$16K
EVLO
644
PUT
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-1,035
Closed -$256K
ABB
645
CALL
DELISTED
ABB Ltd
ABB
-15,500
Closed -$544K
PRVB
646
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-20,251
Closed -$131K
OIG
647
CALL
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-1,075
Closed -$200K
OIG
648
PUT
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
-140
Closed -$26K
PLXP
649
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-13,109
Closed -$263K
RFP
650
DELISTED
Resolute Forest Products Inc.
RFP
-11,397
Closed -$126K

Similar funds

Belvedere Trading's Q3 2021 Portfolio in Review

As of Q3 2021, Belvedere Trading held 683 positions worth $3.82B, up 184% from $1.34B the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Belvedere Trading deployed $2.44B of net new capital in Q3 2021, opening 348 new positions and adding to 67 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 192,540 shares worth $86.1M.

By sector, the portfolio is most concentrated in Technology at 4.2% of assets, down from 7.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amazon, an estimated $30.5M trimmed.

  • Belvedere Trading's largest Q3 2021 buy was State Street SPDR S&P 500 ETF Trust: 192,540 shares worth $86.1M.
  • Belvedere Trading added most to Apple in Q3 2021, an estimated $57.7M increase.
  • Belvedere Trading's biggest Q3 2021 reduction was Amazon, cutting an estimated $30.5M.
  • Belvedere Trading fully exited Tesla in Q3 2021, selling an estimated $12.5M.
  • Belvedere Trading's ten largest holdings make up 93% of its $3.82B portfolio in Q3 2021.
  • Belvedere Trading opened 348 new positions and closed 206 in Q3 2021.
  • Belvedere Trading's portfolio value rose 184% quarter-over-quarter to $3.82B.

Based on Belvedere Trading's 13F filing for Q3 2021, filed 19 Oct 2021.